Abstract:Objective: To investigate the liver protective effect of engeletin (Eng) on rats with hepatocirrhosis by regulating protein kinase R-like endoplasmic reticulum kinase (PERK) - activating transcription factor 4 (ATF4) signaling pathway. Methods: 10 rats were randomly selected as the control group (NC group), and the rest of the rats were induced into the HC rat model. After successful modeling, they were randomly divided into HC group, L-Eng group (10mg·kg-1·d-1), M-Eng group (20mg·kg-1·d-1), H-Eng group (40mg·kg-1·d-1), and H-Eng+CCT group (40mg·kg-1·d-1 Eng+2 mg·kg-1·d-1 CCT020312), 10 rats in each group, lasting for 3 weeks. Detection of liver function indicators, liver histopathological changes α- Expression of SMA, Collagen, EMT marker protein, PERK-ATF4 pathway protein. Results: The NC group had normal liver tissue structure, clear staining and no fibrosis; the HC group showed extensive necrosis, massive lymphocyte infiltration, disorganized liver cords, fibrous hyperplasia and pseudobullet formation; after Eng treatment, lymphocyte infiltration was reduced, cells were more neatly arranged and fibrous hyperplasia improved; compared with the NC group, the HC group showed significantly higher Ishak score, Ishak stage, liver index , alanine aminotransferase (ALT), aspartate aminotransferase (AST) levels, α-SMA, Collagen levels, Vimentin, PERK, ATF4 protein levels were significantly increased (P<0.05), and albumin (ALB), total protein (TP) levels, E-cadherin protein levels were significantly downregulated in the HC group compared with the NC group (P<0.05); the above indexes were improved after Eng treatment, and the effect of Eng showed a dose-dependent effect; CCT020312 reversed the favorable effect of H-Eng on HC rats.Conclusion: Engeletin may play a liver protective role in HC rats by regulating PERK-ATF4 signaling pathway.
代莹, 邓炯, 陆逸君, 温旭东. 黄杞苷下调PERK-ATF4信号通路改善肝硬化大鼠肝脏的作用[J]. 河北医学, 2023, 29(5): 737-742.
DAI Ying, DENG Jiong, LU Yijun, et al. Engeletin Down-Regulates the PERK-ATF4 Signaling Pathway to Improve the Liver of Hepatocirrhosis Rats. HeBei Med, 2023, 29(5): 737-742.